ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00160667
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : October 18, 2010
Sponsor:
Information provided by:
UCB Pharma

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2006
  Actual Study Completion Date : January 2006

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 26, 2017
July 27, 2018
2 August 21, 2018